Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 4/20 | 0.74 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.74 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | PDE4B | Q07343 | 5/20 | 0.49 |
| ▸ | KMO | O15229 | 2/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.49 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.46 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2866244 | 0.88 | HDAC1 (0.71) | HDAC1HDAC8HDAC6ALDH1A1PDE4B | |
| SCHEMBL287420 | 0.88 | ALDH1A1 (0.74) | HDAC1HDAC8HDAC6ALDH1A1PDE4B | |
| SCHEMBL12522824 | 0.88 | HDAC1 (0.58) | HDAC1HDAC8HDAC6ALDH1A1PDE4B | |
| SCHEMBL31558487 | 0.84 | PDE4B (0.63) | HDAC1HDAC8HDAC6ALDH1A1PDE4B | |
| SCHEMBL2868465 | 0.84 | ADRB2 (0.55) | HDAC1HDAC8HDAC6ALDH1A1PDE4B | |
| SCHEMBL12521272 | 0.83 | HDAC1 (0.72) | HDAC1HDAC8HDAC6ALDH1A1PDE4B | |
| SCHEMBL2872214 | 0.82 | HDAC1 (0.52) | HDAC1HDAC8HDAC6ALDH1A1PDE4B | |
| SCHEMBL12521298 | 0.81 | HDAC1 (0.51) | HDAC1HDAC8HDAC6ALDH1A1PDE4B | |
| SCHEMBL2638386 | 0.81 | ADRB2 (0.53) | HDAC1HDAC8HDAC6ALDH1A1PDE4B | |
| SCHEMBL31604686 | 0.81 | KMO (0.54) | HDAC1HDAC8HDAC6ALDH1A1PDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2307394-B1 | SULPHONAMIDES AS VANILLOID RECEPTOR ANTAGONIST | AMOREPACIFIC CORP (KR) | 2012-09-26 | — | — | EP | disclosed |
| WO-2010002209-A2 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | AMOREPACIFIC CORPORATION (KR) | 2010-01-07 | — | — | WO | disclosed |